Branded

05/21/2013 - 2:02pm

Impax ships authorized generic version of Zomig

Impax Labs has launched an authorized generic drug for migraine headaches under a partnership with AstraZeneca, Impax said.

05/21/2013 - 10:41am

Morning sickness pill launched

Drug maker Duchesnay USA has launched a new treatment for morning sickness, the company announced.

05/21/2013 - 10:21am

Court upholds Mylan's patents on COPD drug

A federal appellate court has ruled in favor of Mylan in a case involving a drug for chronic obstructive pulmonary disease, the drug maker said.

05/20/2013 - 10:27am

Actavis, Warner Chilcott reach acquisition deal

Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.

05/17/2013 - 11:31am

FDA advisory committee to meet in July on opioid painkiller

A Food and Drug Administration panel will consider whether to recommend approval for an experimental painkiller in July, the drug's developer said Friday.

05/15/2013 - 4:35pm

FDA approves J&J's Simponi for ulcerative colitis

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis, the agency said Wednesday.

05/15/2013 - 3:18pm

Committee advances bill to secure pharmaceutical supply chain

A federal drug track-and-trace bill has made it out of a congressional committee.

05/15/2013 - 2:23pm

FDA approves Genentech drug for lung cancer with genetic mutation

The Food and Drug Administration has approved a drug for a type of lung cancer.

05/15/2013 - 11:33am

FDA approves new prostate cancer drug

A new treatment for late-stage prostate cancer has received approval from the Food and Drug Administration.

05/14/2013 - 3:12pm

Study finds large numbers of students abuse prescription drugs to cope with stress of finals

Finals can be a stressful time for any college or graduate student, with many hours spent studying and few spent socializing or relaxing. But many students are using prescription drugs to get through finals, according to a new study.